Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joris Menten

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2012
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasisJane Cunningham, Epco Hasker, Pradeep Das, et al.
Plos Neglected Tropical Diseases|April 10, 2015
Long-lasting insecticidal nets to prevent visceral leishmaniasis in the Indian subcontinent; methodological lessons learned from a cluster randomised controlled trialAlbert Picado, Bart Ostyn, Suman Rijal, et al.
Clinical Therapeutics|September 21, 2002
A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placementCraig P Juergens, Harvey D White, Jorge A Belardi, et al.
Plos Neglected Tropical Diseases|October 3, 2015
Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort StudyErmias Diro, Koert Ritmeijer, Marleen Boelaert, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2015
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and PreventionJordan K Kyongo, Tania Crucitti, Joris Menten, et al.
The New England Journal of Medicine|February 15, 2023
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older AdultsAnn R Falsey, Kristi Williams, Efi Gymnopoulou, et al.
The Journal of Infectious Diseases|January 5, 2021
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge StudyJerald Sadoff, Els De Paepe, John DeVincenzo, et al.
BMC Infectious Diseases|April 19, 2015
Correlates of the molecular vaginal microbiota composition of African womenRaju Gautam, Hanneke Borgdorff, Vicky Jespers, et al.
Tropical Medicine & International Health : TM & IH|September 18, 2014
Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and ZambiaOlivier Koole, Sharon Tsui, Fred Wabwire-Mangen, et al.
AIDS (London, England)|February 18, 2015
Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and ZambiaJulie A Denison, Olivier Koole, Sharon Tsui, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2012
A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasisJane Cunningham, Epco Hasker, Pradeep Das, et al.
Plos Neglected Tropical Diseases|April 10, 2015
Long-lasting insecticidal nets to prevent visceral leishmaniasis in the Indian subcontinent; methodological lessons learned from a cluster randomised controlled trialAlbert Picado, Bart Ostyn, Suman Rijal, et al.
Clinical Therapeutics|September 21, 2002
A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placementCraig P Juergens, Harvey D White, Jorge A Belardi, et al.
Plos Neglected Tropical Diseases|October 3, 2015
Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort StudyErmias Diro, Koert Ritmeijer, Marleen Boelaert, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2015
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and PreventionJordan K Kyongo, Tania Crucitti, Joris Menten, et al.
The New England Journal of Medicine|February 15, 2023
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older AdultsAnn R Falsey, Kristi Williams, Efi Gymnopoulou, et al.
The Journal of Infectious Diseases|January 5, 2021
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge StudyJerald Sadoff, Els De Paepe, John DeVincenzo, et al.
BMC Infectious Diseases|April 19, 2015
Correlates of the molecular vaginal microbiota composition of African womenRaju Gautam, Hanneke Borgdorff, Vicky Jespers, et al.
Tropical Medicine & International Health : TM & IH|September 18, 2014
Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and ZambiaOlivier Koole, Sharon Tsui, Fred Wabwire-Mangen, et al.
AIDS (London, England)|February 18, 2015
Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and ZambiaJulie A Denison, Olivier Koole, Sharon Tsui, et al.
Pageof 10